Korean Market
OWNR
Vivozon Pharmaceutical
★

Vivozon Holdings' Stake Marginally Declines to 31.72% Due to Special Relation's Early Redemption of Convertible Bonds, While Pledge Agreements for Loan Collateral Continue

 
PERI
Vivozon Pharmaceutical
★

VIVOZON PHARM Q1 2026: Sales Down, Net Loss Widens; New Drug Anapra Launched but Financial Pressures Persist

 
OWNR
Vivozon Pharmaceutical
★

Vivozon Files Report on Changes in Executive and Major Shareholder Securities Ownership

 
EXCH
Vivozon Pharmaceutical
★

Decision to Acquire and Cancel 15th Series Convertible Bonds before Maturity (Response to Put Option Exercise)